New #Illumina partnership saves iBIO members on gene sequencing solutions.

0

iBIO Adds Illumina partnership for Gene Sequencing Solutions to Purchasing Program

iBIO is excited to announce that we are now offering our members a program through Illumina for gene sequencing solutions that can offer substantial savings to first time Illumina customers. Illumina technology is responsible for generating more than 90% of the world’s sequencing data. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. This savings program, through BIO Business Solutions®, is the result of collaboration between iBIO and the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology trade association.

Member companies can realize the following benefits of the Illumina program:

• Exclusive rebates on the following benchtop sequencing instrumentation for first-time Illumina customers

Low-throughput Instruments

MiSeq®

Allows small genome sequencing and assembly, and enables detection of targeted variants with unmatched accuracy

MiSeqDx®

First FDA cleared IVD platform with a growing menu of assays that enables clinical laboratories to create and deploy NGS based molecular diagnostic testing in their labs

MiSeq FGxTM

A compact, fully validated NGS platform for forensic genomics applications

MiniSeqTM

Flexible and affordable system that allows researchers to transition easily between sequencing projects for both DNA and RNA

Mid-throughput Instruments

NextSeq®500

Enables rapid sequencing of exomes, targeted panels, and transcriptions

NextSeq®550

Enables NGS and Cytogenetic Array Scanning on one instrument

For Research Use Only. Not for use in diagnostic procedures.

For more information about the program and a full list of benefits, please visit http://bbs.bio.org/content/illumina.

 

Share This Post:

Comments are closed.